Hallmarks of sarcopenia and sarcopenia classification.
figure
posted on 2024-04-22, 17:22 authored by Paola Sanches Cella, Ricardo Luís Nascimento de Matos, Poliana Camila Marinello, Júlio Cesar da Costa, Felipe Arruda Moura, Ana Paula Frederico Rodrigues Loureiro Bracarense, Patricia Chimin, Rafael DeminiceHallmarks of sarcopenia and sarcopenia classification.
History
Usage metrics
Categories
Keywords
open field testmeasure exploratory capacityconsidered frail basedbody weight lossdoxorubicin administration ledphysical function impairmentsevaluated muscle atrophy7 ): micemuscle mass lossdecreased food intake15 days ).doxorubicin chemotherapy cyclesdoxorubicin exhibited sarcopeniadoxorubicin causes cachexiahuman chemotherapy treatmentmice p10 ): micemuscle massfood intakedoxorubicin treatmentdoxorubicin chemotherapychemotherapy treatmentmice treatedmice subjectedgastrocnemius musclefunctional impairments6 micexlink ">traction methodtotal doseseventeen c57saline solutionp .)overall conditionnegatively impactlocomotor activitykg dividedkey markersintricate relationshipday periodassess sarcopeniaassess cachexia34 %)18 mg13 %)05 ),
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC